Article ; Online: The vasculature: a therapeutic target in heart failure?
2021 Volume 118, Issue 1, Page(s) 53–64
Abstract: It is well established that the vasculature plays a crucial role in maintaining oxygen and nutrients supply to the heart. Increasing evidence further suggests that the microcirculation has additional roles in supporting a healthy microenvironment. Heart ... ...
Abstract | It is well established that the vasculature plays a crucial role in maintaining oxygen and nutrients supply to the heart. Increasing evidence further suggests that the microcirculation has additional roles in supporting a healthy microenvironment. Heart failure is well known to be associated with changes and functional impairment of the microvasculature. The specific ablation of protective signals in endothelial cells in experimental models is sufficient to induce heart failure. Therefore, restoring a healthy endothelium and microcirculation may be a valuable therapeutic strategy to treat heart failure. This review article will summarize the current understanding of the vascular contribution to heart failure with reduced or preserved ejection fraction. Novel therapeutic approaches including next generation pro-angiogenic therapies and non-coding RNA therapeutics, as well as the targeting of metabolites or metabolic signalling, vascular inflammation and senescence will be discussed. |
---|---|
MeSH term(s) | Angiogenesis Inducing Agents/adverse effects ; Angiogenesis Inducing Agents/therapeutic use ; Animals ; Coronary Circulation/drug effects ; Coronary Vessels/drug effects ; Coronary Vessels/metabolism ; Coronary Vessels/physiopathology ; Genetic Therapy/adverse effects ; Heart Failure, Diastolic/genetics ; Heart Failure, Diastolic/metabolism ; Heart Failure, Diastolic/physiopathology ; Heart Failure, Diastolic/therapy ; Heart Failure, Systolic/genetics ; Heart Failure, Systolic/metabolism ; Heart Failure, Systolic/physiopathology ; Heart Failure, Systolic/therapy ; Humans ; Microcirculation/drug effects ; Microvessels/drug effects ; Microvessels/metabolism ; Microvessels/physiopathology ; Neovascularization, Physiologic/drug effects ; RNA, Untranslated/genetics ; RNA, Untranslated/metabolism ; Recovery of Function ; Vaccines/adverse effects ; Vaccines/therapeutic use ; Ventricular Function, Left/drug effects |
Chemical Substances | Angiogenesis Inducing Agents ; RNA, Untranslated ; Vaccines |
Language | English |
Publishing date | 2021-02-23 |
Publishing country | England |
Document type | Journal Article ; Research Support, Non-U.S. Gov't ; Review |
ZDB-ID | 80340-6 |
ISSN | 1755-3245 ; 0008-6363 |
ISSN (online) | 1755-3245 |
ISSN | 0008-6363 |
DOI | 10.1093/cvr/cvab047 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 565: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.